Skip to main content

Table 1 Demographic and baseline characteristics

From: Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer – the CONKO 004 pilot trial

Characteristic: N = 19 (100%)

Chemotherapy + Enoxaparin

Age – Years

 

  Median [range]

59 [46 – 74]

Sex – no. (%)

 

  Female

6 (32)

  Male

13 (68)

KPS – no. (%)

 

  60% - 70%

2 (11)

  80% - 100%

17 (89)

Stage – no. (%)

 

  M0

6 (32)

  M1

13 (68)

   Liver and lung

1(5)

   Liver

8 (41)

   Lung

2 (11)

   Other

2 (11)

Primary cancer – no. (%)

12 (63)

Recurrent cancer – no. (%)

7 (37)

  Site of recurrence

 

   Liver

5 (71)

   Local

2 (37)